Marta Izquierdo

Summary

Country: Spain

Publications

  1. ncbi [Gene therapy in neuro-oncology]
    M Izquierdo
    Departamento de Biologia Molecular, Centro de Biologia Molecular Severo Ochoa, Facultad de Ciencias, Universidad Autonoma de Madrid, Madrid, Spain
    Rev Neurol 43:613-7. 2006
  2. ncbi Short interfering RNAs as a tool for cancer gene therapy
    Marta Izquierdo
    Department of Molecular Biology, Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid, Facultad de Ciencias, Madrid, Spain
    Cancer Gene Ther 12:217-27. 2005
  3. ncbi Cyclin E1 knockdown induces apoptosis in cancer cells
    Esteban N Gurzov
    Departament of Molecular Biology, , , Facultad de Ciencias, Cantoblanco, Madrid 28049, Spain
    Neurol Res 28:493-9. 2006
  4. ncbi An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells
    Jon Gil-Ranedo
    Departamento de Biologia Molecular, Universidad Autonoma de Madrid, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas, Instituto Sanitario Ramón y Cajal, Madrid, Spain
    PLoS ONE 6:e28753. 2011
  5. ncbi Combination of KIT gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis
    Irene Ruano
    Centro de Biología Molecular Severo Ochoa CSIC, Departamento de Biología Molecular Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain
    Br J Haematol 148:59-68. 2010
  6. ncbi Selective RNAi-mediated inhibition of mutated c-kit
    Irene Ruano
    Centro de Biologia Molecular Severo Ochoa, CSIC UAM, Universidad Autonoma de Madrid, Departamento de Biologia Molecular, C Nicolás Cabrera, 1 Campus de Cantoblanco, Madrid, Spain
    J RNAi Gene Silencing 5:339-44. 2009
  7. ncbi Construction and characterization of pentacistronic retrovirus vectors
    Pablo de Felipe
    , , Facultad de Ciencias, Cantoblanco, 28049 Madrid, Spain
    J Gen Virol 84:1281-5. 2003
  8. ncbi RNA interference against Hec1 inhibits tumor growth in vivo
    E N Gurzov
    Department of Molecular Biology, , , Facultad de Ciencias, Cantoblanco, Madrid, Spain
    Gene Ther 13:1-7. 2006
  9. ncbi Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy
    P de Felipe
    Departamento de Bioquimica y Biologia Molecular, Universidad Autonoma de Madrid, Facultad de Ciencias, Spain
    Gene Ther 6:198-208. 1999

Collaborators

  • Esteban N Gurzov
  • Irene Ruano
  • Jon Gil-Ranedo
  • Pablo de Felipe
  • Mercedes Garcia-Villanueva
  • Marina Mendiburu-Eliçabe
  • Marta del Alamo
  • Diego Medina
  • Ricardo Gargini
  • P de Felipe
  • M L Cortés
  • M Ryan
  • V Martin

Detail Information

Publications10

  1. ncbi [Gene therapy in neuro-oncology]
    M Izquierdo
    Departamento de Biologia Molecular, Centro de Biologia Molecular Severo Ochoa, Facultad de Ciencias, Universidad Autonoma de Madrid, Madrid, Spain
    Rev Neurol 43:613-7. 2006
    ..At present, the majority of these procedures are in clinical phases but none as yet is considered a therapeutic option...
  2. ncbi Short interfering RNAs as a tool for cancer gene therapy
    Marta Izquierdo
    Department of Molecular Biology, Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid, Facultad de Ciencias, Madrid, Spain
    Cancer Gene Ther 12:217-27. 2005
    ..RNAi against multidrug resistance genes or chemoresistance targets may also provide useful cancer treatments. Studies investigating these approaches in preclinical models are also reviewed...
  3. ncbi Cyclin E1 knockdown induces apoptosis in cancer cells
    Esteban N Gurzov
    Departament of Molecular Biology, , , Facultad de Ciencias, Cantoblanco, Madrid 28049, Spain
    Neurol Res 28:493-9. 2006
    ..DISCUSSION: Our results indicate that retrovirus carrying the DNA to be transcribed into a short hairpin RNA (shRNA) against cyclin E1 could be used as a therapeutic agent for cancer therapy...
  4. ncbi An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells
    Jon Gil-Ranedo
    Departamento de Biologia Molecular, Universidad Autonoma de Madrid, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas, Instituto Sanitario Ramón y Cajal, Madrid, Spain
    PLoS ONE 6:e28753. 2011
    ..The use of this shRNA may contribute to develop new therapeutic approaches for this incurable type of brain tumor...
  5. ncbi Combination of KIT gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis
    Irene Ruano
    Centro de Biología Molecular Severo Ochoa CSIC, Departamento de Biología Molecular Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain
    Br J Haematol 148:59-68. 2010
    ..Targeting kit in the presence of alpha-TOS represents a new approach against proliferation of human mast leukaemia cell lines...
  6. ncbi Selective RNAi-mediated inhibition of mutated c-kit
    Irene Ruano
    Centro de Biologia Molecular Severo Ochoa, CSIC UAM, Universidad Autonoma de Madrid, Departamento de Biologia Molecular, C Nicolás Cabrera, 1 Campus de Cantoblanco, Madrid, Spain
    J RNAi Gene Silencing 5:339-44. 2009
    ..2 cells which are resistant to the Kit tyrosine kinase inhibitor, imatinib mesylate...
  7. ncbi Construction and characterization of pentacistronic retrovirus vectors
    Pablo de Felipe
    , , Facultad de Ciencias, Cantoblanco, 28049 Madrid, Spain
    J Gen Virol 84:1281-5. 2003
    ..9 kb) were comparable to those of vector systems with shorter genomes. Other vectors constructed that exceeded the genome length of the wild-type virus suffered frequent deletions...
  8. ncbi RNA interference against Hec1 inhibits tumor growth in vivo
    E N Gurzov
    Department of Molecular Biology, , , Facultad de Ciencias, Cantoblanco, Madrid, Spain
    Gene Ther 13:1-7. 2006
    ..These results indicate that depletion of Hec1 could be used as a new strategy to block the dividing cell, and therefore against cancer...
  9. ncbi Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy
    P de Felipe
    Departamento de Bioquimica y Biologia Molecular, Universidad Autonoma de Madrid, Facultad de Ciencias, Spain
    Gene Ther 6:198-208. 1999
    ..Transcription and translation gives rise to a bicistronic mRNA and two independent protein products. The system offers advantages to other alternative ways to create polycistronic mRNAs and can be used in gene therapy delivery vectors...